Boxer Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,514,520
+43668.5%
1,094,0000.0%1.20%
-49.7%
Q2 2023$51,440
+12.1%
1,094,0000.0%2.39%
+5.8%
Q1 2023$45,904
-99.9%
1,094,0000.0%2.26%
+2.5%
Q4 2022$41,725,160
-2.6%
1,094,0000.0%2.20%
-8.7%
Q3 2022$42,841,000
+21.2%
1,094,0000.0%2.41%
+7.6%
Q2 2022$35,336,000
-2.4%
1,094,0000.0%2.24%
+20.3%
Q1 2022$36,211,000
-22.2%
1,094,0000.0%1.86%
+2.9%
Q4 2021$46,539,000
-4.0%
1,094,0000.0%1.81%
+6.8%
Q3 2021$48,475,000
-22.0%
1,094,0000.0%1.69%
-22.8%
Q2 2021$62,150,000
-24.1%
1,094,0000.0%2.19%
-21.0%
Q1 2021$81,886,000
-13.5%
1,094,0000.0%2.78%
-8.7%
Q4 2020$94,642,000
+41.5%
1,094,0000.0%3.04%
+31.6%
Q3 2020$66,865,000
+47.0%
1,094,0000.0%2.31%
+15.6%
Q2 2020$45,489,000
+3.4%
1,094,000
-28.6%
2.00%
-33.3%
Q1 2020$44,014,000
+74.2%
1,532,510
+337.9%
3.00%
+109.9%
Q4 2019$25,267,000350,0001.43%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders